Anhui Anke BioTech Group (300009) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Anhui Anke BioTech Group (300009) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥240.51 Million ≈ $35.19 Million USD) by net assets (CN¥4.34 Billion ≈ $635.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Anhui Anke BioTech Group (300009) defensive interval to measure how many days the company can operate on defensive assets alone.

Anhui Anke BioTech Group - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Anhui Anke BioTech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anhui Anke BioTech Group Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Anke BioTech Group ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zen Technologies Limited NSE:ZENTEC	-0.079x
Nanjing Gaoke Co Ltd SHG:600064	0.010x
Wuxi Boton Technology Co Ltd SHE:300031	0.008x
Shunsin Technology Holdings Ltd TW:6451	-0.044x
Ningbo PIA Automation Holding Corp. A SHG:688306	N/A
Charter Hall Long Wale REIT AU:CLW	0.027x
AG Anadolu Group Holding IS:AGHOL	0.114x
Taiwan Cogeneration Corp TW:8926	-0.003x

Annual Cash Flow Conversion Efficiency for Anhui Anke BioTech Group (2006–2024)

The table below shows the annual cash flow conversion efficiency of Anhui Anke BioTech Group from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Anhui Anke BioTech Group (300009) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.30 Billion ≈ $629.22 Million	CN¥685.37 Million ≈ $100.29 Million	0.159x	-36.37%
2023-12-31	CN¥3.93 Billion ≈ $575.42 Million	CN¥985.01 Million ≈ $144.14 Million	0.250x	+21.91%
2022-12-31	CN¥3.40 Billion ≈ $497.78 Million	CN¥698.98 Million ≈ $102.28 Million	0.205x	+0.75%
2021-12-31	CN¥2.90 Billion ≈ $424.88 Million	CN¥592.17 Million ≈ $86.65 Million	0.204x	+28.50%
2020-12-31	CN¥2.93 Billion ≈ $428.54 Million	CN¥464.80 Million ≈ $68.01 Million	0.159x	+44.95%
2019-12-31	CN¥2.70 Billion ≈ $395.10 Million	CN¥295.63 Million ≈ $43.26 Million	0.109x	-23.41%
2018-12-31	CN¥2.01 Billion ≈ $294.29 Million	CN¥287.49 Million ≈ $42.07 Million	0.143x	-10.32%
2017-12-31	CN¥1.76 Billion ≈ $257.60 Million	CN¥280.63 Million ≈ $41.06 Million	0.159x	-11.88%
2016-12-31	CN¥1.43 Billion ≈ $208.70 Million	CN¥258.01 Million ≈ $37.75 Million	0.181x	+92.66%
2015-12-31	CN¥1.26 Billion ≈ $185.03 Million	CN¥118.73 Million ≈ $17.37 Million	0.094x	-33.17%
2014-12-31	CN¥773.47 Million ≈ $113.18 Million	CN¥108.68 Million ≈ $15.90 Million	0.141x	+74.44%
2013-12-31	CN¥660.60 Million ≈ $96.67 Million	CN¥53.21 Million ≈ $7.79 Million	0.081x	-13.16%
2012-12-31	CN¥580.03 Million ≈ $84.88 Million	CN¥53.80 Million ≈ $7.87 Million	0.093x	+602.56%
2011-12-31	CN¥543.88 Million ≈ $79.59 Million	CN¥7.18 Million ≈ $1.05 Million	0.013x	-85.46%
2010-12-31	CN¥522.30 Million ≈ $76.43 Million	CN¥47.43 Million ≈ $6.94 Million	0.091x	+16.32%
2009-12-31	CN¥495.41 Million ≈ $72.49 Million	CN¥38.67 Million ≈ $5.66 Million	0.078x	-55.44%
2008-12-31	CN¥148.64 Million ≈ $21.75 Million	CN¥26.04 Million ≈ $3.81 Million	0.175x	-31.56%
2007-12-31	CN¥137.09 Million ≈ $20.06 Million	CN¥35.10 Million ≈ $5.14 Million	0.256x	+5.30%
2006-12-31	CN¥122.00 Million ≈ $17.85 Million	CN¥29.66 Million ≈ $4.34 Million	0.243x	--

About Anhui Anke BioTech Group

SHE:300009 China Biotechnology

Market Cap

$1.88 Billion

CN¥12.82 Billion CNY

Market Cap Rank

#6525 Global

#1413 in China

Share Price

CN¥7.67

Change (1 day)

+0.13%

52-Week Range

CN¥7.66 - CN¥12.30

All Time High

CN¥127.71